Ping Zhang

6.5k total citations
140 papers, 2.8k citations indexed

About

Ping Zhang is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ping Zhang has authored 140 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 31 papers in Immunology and 20 papers in Cancer Research. Recurrent topics in Ping Zhang's work include interferon and immune responses (16 papers), Cancer-related molecular mechanisms research (10 papers) and Viral Infections and Vectors (8 papers). Ping Zhang is often cited by papers focused on interferon and immune responses (16 papers), Cancer-related molecular mechanisms research (10 papers) and Viral Infections and Vectors (8 papers). Ping Zhang collaborates with scholars based in China, United States and United Kingdom. Ping Zhang's co-authors include Charles E. Samuel, Bomiao Cui, Xuedong Zhou, Xiaobo Duan, Ruoshi Xu, Quan Yuan, Jianghua Chen, Lili Chen, Congcong Wu and Junhao Cheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ping Zhang

126 papers receiving 2.7k citations

Peers

Ping Zhang
Long Chen China
Hang‐Rae Kim South Korea
Hiroki Yamaguchi Japan
Hiroshi Suzuki Japan
Adriana K. Carmona Brazil
Hua‐Lin Wu Taiwan
Massimo Alfano Italy
Hugh Mitchell United States
Long Chen China
Ping Zhang
Citations per year, relative to Ping Zhang Ping Zhang (= 1×) peers Long Chen

Countries citing papers authored by Ping Zhang

Since Specialization
Citations

This map shows the geographic impact of Ping Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Zhang more than expected).

Fields of papers citing papers by Ping Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Zhang. The network helps show where Ping Zhang may publish in the future.

Co-authorship network of co-authors of Ping Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Zhang. A scholar is included among the top collaborators of Ping Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Zhang. Ping Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Tao, Max Ruzanov, David Critton, et al.. (2025). Orthosteric STING inhibition elucidates molecular correction of SAVI STING. Nature Communications. 16(1). 5695–5695. 2 indexed citations
2.
Jiang, Lan, Ping Zhang, Chunmei Li, et al.. (2025). Prognostic role of circRNAs and RNA methylation enzymes in bladder cancer: A systematic review and meta-analysis of Chinese studies. Urologic Oncology Seminars and Original Investigations. 43(11). 628–638. 1 indexed citations
3.
4.
5.
Paz‐Ares, Luis, Shobhit Baijal, Pilar Garrido, et al.. (2024). 1314P Patient-reported outcomes (PROs) from the phase III EVOKE-01 trial of sacituzumab govitecan (SG) vs docetaxel (doc) in metastatic non-small cell lung cancer (mNSCLC). Annals of Oncology. 35. S836–S838. 1 indexed citations
6.
Wu, Yi‐Long, Zhichen Wang, Y. Cheng, et al.. (2024). 1255MO A phase II safety and efficacy study of PM8002/BNT327 in combination with chemotherapy in patients with EGFR-mutated non-small cell lung cancer (NSCLC). Annals of Oncology. 35. S804–S804. 6 indexed citations
7.
Wang, Yinping, Huangdu Hu, Qiucheng Shi, et al.. (2024). Prevalence and characteristics of ertapenem-mono-resistant isolates among carbapenem-resistant Enterobacterales in China. Emerging Microbes & Infections. 13(1). 2332658–2332658. 1 indexed citations
8.
Torrance, Hew D.T., Ping Zhang, Yuxin Mi, et al.. (2023). A Transcriptomic Approach to Understand Patient Susceptibility to Pneumonia After Abdominal Surgery. Annals of Surgery. 279(3). 510–520. 2 indexed citations
9.
Li, Wei, Yuanyuan Zhang, Kuan Wang, et al.. (2023). Screening and identification of the core immune‐related genes and immune cell infiltration in severe burns and sepsis. Journal of Cellular and Molecular Medicine. 27(11). 1493–1508. 4 indexed citations
10.
Wang, Haifeng, Junfeng Chu, Ping Zhang, et al.. (2020). Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Si, Xiaoyan, Ruili Pan, Shaohua Ma, et al.. (2020). Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer. Thoracic Cancer. 12(3). 357–363. 18 indexed citations
12.
Wang, Huijun, Yulan Lu, Xinran Dong, et al.. (2020). Optimized trio genome sequencing (OTGS) as a first-tier genetic test in critically ill infants: practice in China. Human Genetics. 139(4). 473–482. 40 indexed citations
13.
Zhang, Ping, Matthias Glanemann, Marina Mione, et al.. (2019). Fam83F induces p53 stabilisation and promotes its activity. Cell Death and Differentiation. 26(10). 2125–2138. 15 indexed citations
14.
Li, Yuye, Siyu Wu, Jun Xia, et al.. (2013). Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells. PLoS ONE. 8(1). e55108–e55108. 16 indexed citations
15.
Huang, Xi, et al.. (2012). miR146a facilitates DENV2 replication by targeting TRAF6 and inhibiting interferon production (168.19). The Journal of Immunology. 188(1_Supplement). 168.19–168.19. 1 indexed citations
16.
Zhang, Ping, et al.. (2011). Separation Technology of Polysaccharides from FRUCTUS LYCII by Ultrafiltration Method. Medicinal plant. 2(8). 61–65. 1 indexed citations
17.
Zhang, Ping, et al.. (2010). Development of a Protein Biochip to Identify 6 Monoclonal Antibodies Against Subtypes of Recombinant Human Interferons. Assay and Drug Development Technologies. 8(2). 212–218. 3 indexed citations
18.
Zhang, Ping. (2010). Changes of mn23-H1 gene expression in human peripheral blood cell after X-ray irradiation. Zhonghua fangshe yixue yu fanghu zazhi. 30(2). 161–164. 1 indexed citations
19.
Zhang, Ping, Neil Moudgill, Eric Hager, et al.. (2010). Endothelial Differentiation of Adipose-Derived Stem Cells from Elderly Patients with Cardiovascular Disease. Stem Cells and Development. 20(6). 977–988. 82 indexed citations
20.
Zhang, Ping, et al.. (2009). Construction and analysis of Populus deltoides SSH cDNA library induced by Tetra lobulifera (Keifer).. Nanjing Linye Daxue xuebao. 33(2). 5–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Long Chen Breakdown of academic impact, for papers by Hang‐Rae Kim Breakdown of academic impact, for papers by Hiroki Yamaguchi Breakdown of academic impact, for papers by Hiroshi Suzuki Breakdown of academic impact, for papers by Adriana K. Carmona Breakdown of academic impact, for papers by Hua‐Lin Wu Breakdown of academic impact, for papers by Massimo Alfano Breakdown of academic impact, for papers by Hugh Mitchell
Rankless by CCL
2026